ARCHIVES

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

This article is from The Cancer Letter archive.

Vol. 14 No. 25 | June 17, 1988

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004